デフォルト表紙
市場調査レポート
商品コード
1404823

仙腸関節固定術の市場規模、シェア、動向分析レポート:適応症別、治療タイプ別、エンドユーザー別、地域別、セグメント別予測、2024年~2030年

Sacroiliac Joint Fusion Market Size, Share & Trends Analysis Report By Indication (Degenerative Sacroiliitis, Sacral Disruption), By Treatment Type (Surgery, Injections), By End-user, By Region, And Segment Forecasts, 2024 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 162 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.46円
仙腸関節固定術の市場規模、シェア、動向分析レポート:適応症別、治療タイプ別、エンドユーザー別、地域別、セグメント別予測、2024年~2030年
出版日: 2023年11月30日
発行: Grand View Research
ページ情報: 英文 162 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

仙腸関節固定術市場の成長と動向:

Grand View Research, Inc.の最新レポートによると、世界の仙腸関節固定術市場規模は2030年までに24億9,000万米ドルに達する見込みです。

2024年から2030年までにCAGR 19.8%で成長すると予測されています。市場開拓の主な企業は、革新的で効果的なデバイスを開発するために研究開発(R&D)活動に多額の投資を行っています。このような研究開発活動の増加は、今後数年間の市場成長を促進すると予想されます。また、骨疾患の有病率の増加や技術の進歩が進んでいることから、市場はさらに成長すると予想されます。

腰痛、臀部痛、鼠径部痛、下肢痛の有病率の増加は、SI関節固定術市場の成長を促進します。これらの慢性的で衰弱させるような形態の痛みは、驚くほど一般的になっており、世界人口のかなりの部分に影響を及ぼしています。この動向はヘルスケアシステムに大きな課題を突きつけ、苦痛を和らげ、運動能力を回復させる革新的なソリューションへの需要を煽っています。メディケア&メディケイド・サービスセンターが2021年12月に報告したように、腰、臀部、鼠径部、下肢の慢性疼痛はSI関節障害の症例の大部分を占め、その10%~26%を占めています。SI関節障害に関連する症状の有病率は、そのヘルスケアの大きな課題を浮き彫りにしています。

さらに、市場開拓を後押しする要因として、より改良された安全なSI関節固定システムを開発するために、革新的な材料や技術の使用が増加していることが挙げられます。例えば、2022年10月、低侵襲アプローチに焦点を当てた再生技術を専門とする企業であるオーロラ・スパイン社は、特許取得済みのSiLO TFX MISについて米国FDAから510(k)認可を取得したと発表しました。このSI関節固定システムは、SI関節破壊や退行性仙腸炎を伴う症例におけるSI関節固定を目的とした低侵襲ソリューションです。SiLO TFXシステムは、腸骨スクリュー、仙骨スクリュー、関連器具、トランスフィクシングコーンで構成され、仙骨と腸骨間の骨癒合の固定と安定性を達成するように設計されています。従って、このような技術的進歩が市場成長を押し上げると予想されます。

2023年には北米が最大の収益シェアで市場を独占しました。北米は世界の上肢義肢市場をリードしています。この優位性は、先進ヘルスケアインフラ、主要企業の存在、償還範囲の拡大に起因しています。主要企業は、市場シェア拡大のため、自社製品の臨床試験、地域拡大、特許申請、製品発売、提携・協力などの戦略的イニシアチブの実施に取り組んでいます。

仙腸関節固定術市場のレポートハイライト

  • 適応症別では、退行性仙腸関節炎セグメントが2023年に38.6%の最大収益シェアを占めました。この疾患に対する意識の高まりと、仙腸関節障害の診断能力の向上が、このセグメントの成長を促進する主な要因の1つです。
  • 治療タイプ別では、2023年の収益シェアで手術セグメントが市場を独占しました。その優位性は、より小さな切開、痛みと傷跡の減少、迅速な回復期間などの利点によって、低侵襲手術への嗜好が高まっていることに起因しています。
  • 最終用途別では、病院セグメントが2023年の市場を独占しました。病院は患者に専門的で長期的なケアを提供し、その治療はしばしば償還の対象となるため、その採用がさらに促進されます。
  • 北米は、確立されたヘルスケアインフラと企業による研究開発投資の増加により、2023年に最大の収益シェアを占めました。
  • アジア太平洋地域は、大規模な患者プールの存在、医療施設の発展、主要企業による投資により、予測期間中に最も速い速度で成長すると予想されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 仙腸関節融合市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 仙腸関節融合市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 仙腸関節固定術市場:適応症の推定・動向分析

  • 定義と範囲
    • 変性仙腸炎
    • 仙骨破壊
    • トラウマ
  • 適応症の市場シェア、2023年および2030年
  • セグメントダッシュボード
  • 適応症別の世界の仙腸関節固定術市場の見通し
  • 以下の市場規模、予測および動向分析、2018年~2030年
    • 変性仙腸炎
    • 仙骨破壊
    • トラウマ

第5章 仙腸関節固定術市場:治療タイプの推定・動向分析

  • 定義と範囲
    • 手術
    • 注射
    • 高周波アブレーション
  • 治療タイプの市場シェア、2023年および2030年
  • セグメントダッシュボード
  • 治療タイプ別の世界の仙腸関節固定術市場の見通し
  • 以下の市場規模、予測および動向分析、2018年~2030年
    • 手術
    • 注射
    • 高周波アブレーション

第6章 仙腸関節融合市場:エンドユーザーの推定・動向分析

  • 定義と範囲
    • 病院
    • 外来手術センター
    • その他
  • エンドユーザー市場シェア、2023年および2030年
  • セグメントダッシュボード
  • エンドユーザー展望別の世界の仙腸関節融合市場
  • 以下の市場規模、予測および動向分析、2018年~2030年
    • 病院
    • 外来手術センター
    • その他

第7章 仙腸関節融合市場:地域推定・動向分析

  • 地域市場シェア分析、2023年および2030年
  • 地域市場ダッシュボード
  • 世界の地域市場のスナップショット
  • 市場規模と予測トレンド分析、2018年~2030年:
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第8章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 会社/競合の分類
    • イノベーター
  • ベンダー情勢
    • List of key distributors and channel partners
    • Key customers
    • Key company market share analysis, 2023
    • SI-BONE, Inc.
    • PainTEQ
    • CornerLoc
    • SIGNUS Medizintechnik GmbH
    • Globus Medical
    • Orthofix Medical, Inc.
    • Life Spine, Inc.
    • Camber Spine Technologies, LLC
    • CoreLink Surgical
    • Xtant Medical
    • Surgalign Spine Technologies, Inc.
    • Medtronic
図表

List of Tables

  • 1. List of Abbreviation
  • 2. North America sacroiliac joint fusion market, by region, 2018 - 2030 (USD Million)
  • 3. North America sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 4. North America sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 5. North America sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 6. U.S. sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 7. U.S. sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 8. U.S. sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 9. Canada sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 10. Canada sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 11. Canada sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 12. Europe sacroiliac joint fusion market, by region, 2018 - 2030 (USD Million)
  • 13. Europe sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 14. Europe sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 15. Europe sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 16. Germany sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 17. Germany sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 18. Germany sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 19. UK sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 20. UK sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 21. UK sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 22. France sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 23. France sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 24. France sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 25. Italy sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 26. Italy sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 27. Italy sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 28. Spain sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 29. Spain sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 30. Spain sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 31. Denmark sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 32. Denmark sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 33. Denmark sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 34. Sweden sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 35. Sweden sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 36. Sweden sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 37. Norway sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 38. Norway sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 39. Norway sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 40. Asia Pacific sacroiliac joint fusion market, by region, 2018 - 2030 (USD Million)
  • 41. Asia Pacific sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 42. Asia Pacific sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 43. Asia Pacific sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 44. China sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 45. China sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 46. China sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 47. Japan sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 48. Japan sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 49. Japan sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 50. India sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 51. India sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 52. India sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 53. South Korea sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 54. South Korea sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 55. South Korea sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 56. Australia sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 57. Australia sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 58. Australia sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 59. Thailand sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 60. Thailand sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 61. Thailand sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 62. Latin America sacroiliac joint fusion market, by region, 2018 - 2030 (USD Million)
  • 63. Latin America sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 64. Latin America surgical ablation market, by treatment type, 2018 - 2030 (USD Million)
  • 65. Latin America laparoscopic ablation market, by end user, 2018 - 2030 (USD Million)
  • 66. Brazil sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 67. Brazil sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 68. Brazil sacroiliac joint market, by end user, 2018 - 2030 (USD Million)
  • 69. Mexico sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 70. Mexico sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 71. Mexico surgical ablation market, by end user, 2018 - 2030 (USD Million)
  • 72. Argentina sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 73. Argentina sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 74. Argentina surgical ablation market, by end user, 2018 - 2030 (USD Million)
  • 75. MEA sacroiliac joint fusion market, by region, 2018 - 2030 (USD Million)
  • 76. MEA sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 77. MEA sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 78. MEA sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 79. South Africa sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 80. South Africa sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 81. South Africa sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 82. Saudi Arabia sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 83. Saudi Arabia sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 84. Saudi Arabia sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 85. UAE sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 86. UAE sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 87. UAE sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)
  • 88. Kuwait sacroiliac joint fusion market, by indication, 2018 - 2030 (USD Million)
  • 89. Kuwait sacroiliac joint fusion market, by treatment type, 2018 - 2030 (USD Million)
  • 90. Kuwait sacroiliac joint fusion market, by end user, 2018 - 2030 (USD Million)  

List of Figures

  • 1. Market research process
  • 2. Data triangulation techniques
  • 3. Primary research pattern
  • 4. Primary interviews in North America
  • 5. Primary interviews in Europe
  • 6. Primary interviews in APAC
  • 7. Primary interviews in Latin America
  • 8. Primary interviews in MEA
  • 9. Market research approaches
  • 10. Value-chain-based sizing & forecasting
  • 11. QFD modeling for market share assessment
  • 12. Market formulation & validation
  • 13. Sacroiliac joint fusion market: market outlook
  • 14. Sacroiliac joint fusion competitive insights
  • 15. Parent market outlook
  • 16. Related/ancillary market outlook
  • 17. Penetration and growth prospect mapping
  • 18. Industry value chain analysis
  • 19. Sacroiliac joint fusion market driver impact
  • 20 Sacroiliac joint fusion market restraint impact
  • 21. Sacroiliac joint fusion market strategic initiatives analysis
  • 22. Sacroiliac joint fusion market: Indication movement analysis
  • 23. Sacroiliac joint fusion market: Indication outlook and key takeaways
  • 24. Degenerative sacroiliitis market estimates and forecast, 2018 - 2030
  • 25. Sacral disruption market estimates and forecast, 2018 - 2030
  • 26. Trauma market estimates and forecast, 2018 - 2030
  • 27. Sacroiliac joint fusion market: Treatment Type Movement Analysis
  • 28. Sacroiliac joint fusion market: Treatment Type outlook and key takeaways
  • 29. Surgery market estimates and forecast, 2018 - 2030
  • 30. MIS market estimates and forecast,2018 - 2030
  • 31. Open market estimates and forecast, 2018 - 2030
  • 32. Dorsal & Anterior market estimates and forecast,2018 - 2030
  • 33 Lateral market estimates and forecast, 2018 - 2030
  • 34. Implants market estimates and forecast,2018 - 2030
  • 35. Accessories market estimates and forecast,2018 - 2030
  • 36. Injections market estimates and forecast,2018 - 2030
  • 37. Diagnosis market estimates and forecast,2018 - 2030
  • 38 Treatment market estimates and forecast,2018 - 2030
  • 39. RF ablation market estimates and forecast,2018 - 2030
  • 40 Sacroiliac joint fusion market: End User Movement Analysis
  • 41 Sacroiliac joint fusion market: End User outlook and key takeaways
  • 42 Hospitals market estimates and forecast, 2018 - 2030
  • 43 Ambulatory surgical centers market estimates and forecast,2018 - 2030
  • 44 Others market estimates and forecast, 2018 - 2030
  • 45 Global Sacroiliac joint fusion market: Regional movement analysis
  • 46 Global Sacroiliac joint fusion market: Regional outlook and key takeaways
  • 47 Global Sacroiliac joint fusion market share and leading players
  • 48 North America market share and leading players
  • 49 Europe market share and leading players
  • 50 Asia Pacific market share and leading players
  • 51. Latin America market share and leading players
  • 52. Middle East & Africa market share and leading players
  • 53. North America: SWOT
  • 54. Europe SWOT
  • 55. Asia Pacific SWOT
  • 56. Latin America SWOT
  • 57. MEA SWOT
  • 58. North America, by country
  • 59. North America
  • 60. North America market estimates and forecast, 2018 - 2030
  • 61. U.S.
  • 62. U.S. market estimates and forecast, 2018 - 2030
  • 63. Canada
  • 64. Canada market estimates and forecast, 2018 - 2030
  • 65. Europe
  • 66. Europe market estimates and forecast, 2018 - 2030
  • 67. UK
  • 68. UK market estimates and forecast, 2018 - 2030
  • 69. Germany
  • 70. Germany market estimates and forecast, 2018 - 2030
  • 71.. France
  • 72. France market estimates and forecast, 2018 - 2030
  • 73. Italy
  • 74. Italy market estimates and forecast, 2018 - 2030
  • 75. Spain
  • 76. Spain market estimates and forecast, 2018 - 2030
  • 77. Denmark
  • 78. Denmark market estimates and forecast, 2018 - 2030
  • 79. Sweden
  • 80. Sweden market estimates and forecast, 2018 - 2030
  • 81. Norway
  • 82. Norway market estimates and forecast, 2018 - 2030
  • 83. Asia Pacific
  • 84. Asia Pacific market estimates and forecast, 2018 - 2030
  • 85. China
  • 86. China market estimates and forecast, 2018 - 2030
  • 87. Japan
  • 88. Japan market estimates and forecast, 2018 - 2030
  • 89. India
  • 90. India market estimates and forecast, 2018 - 2030
  • 91. Thailand
  • 92. Thailand market estimates and forecast, 2018 - 2030
  • 93. South Korea
  • 94. South Korea market estimates and forecast, 2018 - 2030
  • 95. Australia
  • 96. Australia market estimates and forecast, 2018 - 2030
  • 97. Latin America
  • 98. Latin America market estimates and forecast, 2018 - 2030
  • 99. Brazil
  • 100. Brazil market estimates and forecast, 2018 - 2030
  • 101. Mexico
  • 102. Mexico market estimates and forecast, 2018 - 2030
  • 103. Argentina
  • 104. Argentina market estimates and forecast, 2018 - 2030
  • 105. Middle East and Africa
  • 106. Middle East and Africa market estimates and forecast, 2018 - 2030
  • 107. South Africa
  • 108. South Africa market estimates and forecast, 2018 - 2030
  • 109. Saudi Arabia
  • 110. Saudi Arabia market estimates and forecast, 2018 - 2030
  • 111. UAE
  • 112. UAE market estimates and forecast, 2018 - 2030
  • 113. Kuwait
  • 114. Kuwait market estimates and forecast, 2018 - 2030
  • 115. Market share of key market players- Sacroiliac joint fusion market
目次
Product Code: GVR-4-68039-805-9

Sacroiliac Joint Fusion Market Growth & Trends:

The global sacroiliac joint fusion market size is expected to reach USD 2.49 billion by 2030, according to a new report by Grand View Research, Inc.It is expected to expand at a CAGR of 19.8% from 2024 to 2030. Key market players are investing substantially in Research & Development (R&D) activities to create innovative and effective devices. This increase in R&D activities is expected to drive market growth over the coming years. In addition, the market is expected to grow further due to the increasing prevalence of bone disorders and ongoing technological advancements.

Increasing prevalence of lower back, buttock, groin, and lower extremity pain drives SI joint fusion market growth. These chronic and debilitating forms of pain have become alarmingly common, affecting a substantial portion of the global population. This trend poses significant challenges to healthcare systems and fuels demand for innovative solutions to alleviate suffering and restore mobility. Chronic pain in the lower back, buttock, groin, and lower extremity represents a significant portion of SI joint disorder cases, comprising 10% to 26% of such cases, as the Centers for Medicare & Medicaid Services reported in December 2021. The prevalence of symptoms associated with SI joint disorders highlights their substantial healthcare challenge.

In addition, a factor propelling market growth is the increasing use of innovative materials and technologies to develop improved and safer SI joint fusion systems. For instance, in October 2022, Aurora Spine, a company specializing in regenerative technologies focusing on minimally invasive approaches, announced that it had received 510(k) clearance from the U.S. FDA for its patented SiLO TFX MIS. The SI joint fixation system is a minimally invasive solution intended for SI joint fusion in cases involving SI joint disruptions and degenerative sacroiliitis. The SiLO TFX system comprises an ilium screw, sacrum screw, associated instrumentation, and transfixing cone designed to achieve fixation and stability for bony fusion between the sacrum and ilium. Thus, such technological advancements are expected to boost market growth.

North America dominated the market with the largest revenue share in 2023. North America is the leading market for upper limb prosthetics across the globe. The dominance can be attributed to advanced healthcare infrastructure, the presence of key companies, and growing reimbursement coverage. Key market players are involved in implementing strategic initiatives, such as conducting clinical tests of their products, regional expansion, patent applications, product launches, and partnerships & collaborations to increase their market share.

Sacroiliac Joint Fusion Market Report Highlights:

  • By indication, the degenerative sacroiliitis segment accounted for the largest revenue share of 38.6% in 2023. Growing awareness about the condition and improving diagnostic capabilities for sacroiliac joint disorders are among the major factors that drive the growth of the segment.
  • By treatment type, surgery segment dominated the market in terms of revenue share in 2023. Its dominance is attributed to the growing preference for minimally invasive surgeries, driven by their advantages, including smaller incisions, decreased pain & scarring, and quicker recovery periods.
  • By end user, the hospitals segment dominated the market in 2023. Hospitals offer specialized, extended care for patients, and their treatments are frequently eligible for reimbursement, further fostering their adoption.
  • North America dominated the market with the largest revenue share in 2023 owing to well-established healthcare infrastructure and increasing R&D investments by companies.
  • Asia Pacific region is expected to grow at the fastest rate during the forecast period, owing to the presence of a large patient pool, developing healthcare facilities, and investments by key companies in this region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Technology
    • 1.1.2. Treatment
    • 1.1.3. Application
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
    • 1.6.3. Volume price analysis (Model 2)
    • 1.6.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Technology outlook
    • 2.2.2. Treatment outlook
    • 2.2.3. Application outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Sacroiliac Joint Fusion Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of lower back, buttock, groin, and lower extremity pain
      • 3.2.1.2. Technological advancements
      • 3.2.1.3. Growing cases of Sacroiliitis or Sacroiliac joint dysfunction
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Lack of awareness
  • 3.3. Sacroiliac Joint Fusion Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Sacroiliac Joint Fusion Market: Indication Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Degenerative sacroiliitis
    • 4.1.2. Sacral disruption
    • 4.1.3. Trauma
  • 4.2. Indication Market Share, 2023 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Sacroiliac Joint Fusion Market by Indication Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. Degenerative sacroiliitis
      • 4.5.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2. Sacral disruption
      • 4.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.3. Trauma
      • 4.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Sacroiliac Joint Fusion Market: Treatment Type Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. Surgery
    • 5.1.2. Injections
    • 5.1.3. RF ablation
  • 5.2. Treatment Type Market Share, 2023 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Global Sacroiliac Joint Fusion Market by Treatment Type Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.5.1. Surgery
      • 5.5.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2. Injections
      • 5.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.3. RF ablation
      • 5.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Sacroiliac Joint Fusion Market: End User Estimates & Trend Analysis

  • 6.1. Definitions and Scope
    • 6.1.1. Hospitals
    • 6.1.2. Ambulatory Surgical Centers
    • 6.1.3. Others
  • 6.2. End user Market Share, 2023 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Global Sacroiliac Joint Fusion Market by End User Outlook
  • 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.5.1. Hospitals
      • 6.5.1.1. Market estimates and forecast 2018 to 2030 (USD million)
    • 6.5.2. Ambulatory surgical centers
      • 6.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.3. Others
      • 6.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Sacroiliac Joint Fusion Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. France market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Norway market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. China market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. India market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.2. Mexico
      • 7.8.2.1. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.3. Argentina
      • 7.8.3.1. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. UAE market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Innovators
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2023
    • 8.3.4. SI-BONE, Inc.
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. PainTEQ
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. CornerLoc
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. SIGNUS Medizintechnik GmbH
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Globus Medical
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Orthofix Medical, Inc.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Life Spine, Inc.
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Camber Spine Technologies, LLC
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. CoreLink Surgical
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Xtant Medical
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives
    • 8.3.14. Surgalign Spine Technologies, Inc.
      • 8.3.14.1. Company overview
      • 8.3.14.2. Financial performance
      • 8.3.14.3. Product benchmarking
      • 8.3.14.4. Strategic initiatives
    • 8.3.15. Medtronic
      • 8.3.15.1. Company overview
      • 8.3.15.2. Financial performance
      • 8.3.15.3. Product benchmarking
      • 8.3.15.4. Strategic initiatives